EssilorLuxottica/€EL
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About EssilorLuxottica
EssilorLuxottica is a French-Italian multinational corporation operating in the eyewear and eye care industry. It was formed through the merger of the French ophthalmic optics company Essilor and the Italian eyewear company Luxottica in 2018. The company designs, manufactures, and distributes ophthalmic lenses, optical equipment, and eyewear, including well-known brands such as Ray-Ban, Oakley, and Persol, as well as licensed brands like Chanel and Prada. Headquartered in Charenton-le-Pont, France, and Milan, Italy, EssilorLuxottica has a global presence with operations in over 150 countries. Its strategic positioning is underscored by its integrated business model that encompasses both retail and wholesale distribution, leveraging its extensive portfolio of proprietary and licensed brands.
- Ticker
- €EL
- Sector
- Health
- Primary listing
- PAR
- Employees
- 213,909
- Headquarters
- Paris, France
- Website
- www.essilorluxottica.com
EssilorLuxottica Metrics
BasicAdvanced
€81B
32.72
€5.35
0.54
€4.00
2.28%
Price and volume
Market cap
€81B
Beta
0.54
52-week high
€317.90
52-week low
€138.00
Average daily volume
890K
Dividend rate
€4.00
Financial strength
Current ratio
0.889
Quick ratio
0.469
Long term debt to equity
0.242
Total debt to equity
0.384
Dividend payout ratio (TTM)
66.92%
Interest coverage (TTM)
10.55%
Profitability
EBITDA (TTM)
5,853
Gross margin (TTM)
60.02%
Net profit margin (TTM)
8.52%
Operating margin (TTM)
12.87%
Effective tax rate (TTM)
23.99%
Revenue per employee (TTM)
€140,000
Management effectiveness
Return on assets (TTM)
3.69%
Return on equity (TTM)
6.72%
Valuation
Price to earnings (TTM)
32.724
Price to revenue (TTM)
2.76
Price to book
2.08
Price to tangible book (TTM)
-34.92
Price to free cash flow (TTM)
21.036
Free cash flow yield (TTM)
4.75%
Free cash flow per share (TTM)
8.325
Dividend yield (TTM)
2.28%
Forward dividend yield
2.28%
Growth
Revenue change (TTM)
7.50%
Earnings per share change (TTM)
3.85%
3-year revenue growth (CAGR)
4.93%
10-year revenue growth (CAGR)
15.57%
3-year earnings per share growth (CAGR)
0.81%
10-year earnings per share growth (CAGR)
3.98%
3-year dividend per share growth (CAGR)
7.39%
10-year dividend per share growth (CAGR)
13.68%
What the Analysts think about EssilorLuxottica
Analyst ratings (Buy, Hold, Sell) for EssilorLuxottica stock.
Analyst projections of the future price of EssilorLuxottica stock.
Bulls say / Bears say
Third-quarter revenue rose 7.2% at constant exchange rates and beat forecasts. Traditional eyewear and eyecare remained strong, with core activities growing 6.5% and eyecare and medtech above 6%. (Reuters)
Asia-Pacific revenue grew 15.7% in the third quarter, while the myopia-management portfolio grew 24%. This gives the group a strong growth engine beyond fashion eyewear and smart glasses. (The Manila Times)
EssilorLuxottica and Meta are widening the smart-glasses range and expanding into more markets, with over 100 styles planned by year-end. New designs, prescription options and broader availability could help the category reach more customers. (EssilorLuxottica)
Wearables revenue growth slowed to 20% in the third quarter from nearly 100% in the previous quarter, and the company faces a tougher comparison in the fourth quarter. Google and other rivals could also make it harder to sustain smart-glasses growth. (Reuters)
Smart glasses may earn lower margins than EssilorLuxottica’s traditional eyewear, while Meta and other technology partners could capture much of the software value. If the new products displace ordinary glasses, the shift could weigh on profitability and pricing power. (Reuters)
Third-quarter constant-currency revenue growth eased to 7.2% from 8.7% in the second quarter, while favourable exchange rates added to reported growth. Tough comparisons could make it harder to maintain recent growth rates into year-end. (The Wall Street Journal)
Data summarised monthly by Lightyear AI. Last updated on 17 Nov 2026.
EssilorLuxottica Financial Performance
Revenues and expenses
EssilorLuxottica Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing EssilorLuxottica
AllEURUSD
Fund name | Fund size | €EL weighting |
|---|---|---|
Amundi CAC 40€C40 | €678M | 3.97% |
iShares STOXX Europe 600 Health Care€EXV4 | €729M | 3.08% |
iShares MSCI Europe Health Care Sector£ESIH | €940M | 2.98% |
iShares MSCI Europe Health Care Sector€ESIH | €940M | 2.98% |
iShares MSCI Europe SRI£IESG | €3.1B | 2.23% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.